2708343-64-8
2708343-64-8
Chemical Structure
L-Lysine-d9 hydrochloride
- CAS No.: 2708343-64-8
- Formula:C6H6D9ClN2O2
- Molecular Weight:191.70
IUPAC Name: L-lysine-2,3,3,4,4,5,5,6,6-d9 hydrochloride
InChIKey: BVHLGVCQOALMSV-AIPDENHHSA-N
SMILES: N[C@@](C(O)=O)([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])N.Cl
Biological Activity: L-Lysine-d9 (hydrochloride) is the deuterium labeled L-Lysine. L-lysine hydrochloride is an essential amino acid for humans with various benefits including treating herpes, increasing calcium absorption, reducing diabetes-related illnesses and improving gut health.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
L-Lysine-d9 hydrochloride | 99.0% | L-Lysine-d9 (hydrochloride) is the deuterium labeled L-Lysine. L-lysine hydrochloride is an essential amino acid for humans with various benefits including treating herpes, increasing calcium absorption, reducing diabetes-related illnesses and improving gut health. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Lysine hydrochloride (Standard) | ≥98% | L-Lysine hydrochloride (Standard) is the analytical standard of L-Lysine hydrochloride. This product is intended for research and analytical applications. L-lysine hydrochloride is an essential amino acid for humans with various benefits including treating herpes, increasing calcium absorption, reducing diabetes-related illnesses and improving gut health. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Lysine-d3 hydrochloride | L-Lysine-d3 (hydrochloride) is the deuterium labeled L-Lysine. L-lysine is an essential amino acid with important roles in connective tissues and carnitine synthesis, energy production, growth in children, and maintenance of immune functions. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Lysine-13C6,15N2 hydrochloride | 99.93% | L-Lysine-13C6,15N2 (hydrochloride) is the 13C- and 15N-labeled L-Lysine hydrochloride. L-lysine hydrochloride is an essential amino acid for humans with various benefits including treating herpes, increasing calcium absorption, reducing diabetes-related illnesses and improving gut health. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Lysine-d8 hydrochloride | 99.88% | L-Lysine-d8 (hydrochloride) is the deuterium labeled L-Lysine hydrochloride. L-lysine hydrochloride is an essential amino acid for humans with various benefits including treating herpes, increasing calcium absorption, reducing diabetes-related illnesses and improving gut health. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Lysine-13C dihydrochloride | 99.90% | L-Lysine-13C (dihydrochloride) is the 13C-labeled L-Lysine dihydrochloride. L-lysine dihydrochloride is an essential amino acid for humans with various benefits including treating herpes, increasing calcium absorption, reducing diabetes-related illnesses and improving gut health. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Lysine-13C6 hydrochloride | 98.0% | L-Lysine-13C6 hydrochloride is the 13C labeled L-Lysine hydrochloride. L-lysine hydrochloride is an essential amino acid for humans with various benefits including treating herpes, increasing calcium absorption, reducing diabetes-related illnesses and improving gut health. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Lysine-15N2 hydrochloride | 98.0% | L-Lysine-15N2 (hydrochloride) is the 15N-labeled L-Lysine hydrochloride. L-lysine hydrochloride is an essential amino acid for humans with various benefits including treating herpes, increasing calcium absorption, reducing diabetes-related illnesses and improving gut health. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Lysine-d4 hydrochloride | 99.78% | L-Lysine-d4 (hydrochloride) is the deuterium labeled L-Lysine. L-lysine hydrochloride is an essential amino acid for humans with various benefits including treating herpes, increasing calcium absorption, reducing diabetes-related illnesses and improving gut health. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Lysine-13C6,15N2,d9 dihydrochloride | 99.4% | L-Lysine-13C6,15N2,d9 (dihydrochloride) is the deuterium, 13C-, and 15-labeled L-Lysine hydrochloride. L-lysine hydrochloride is an essential amino acid for humans with various benefits including treating herpes, increasing calcium absorption, reducing diabetes-related illnesses and improving gut health. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Lysine hydrochloride | 99.95% | L-lysine hydrochloride is an essential amino acid for humans with various benefits including treating herpes, increasing calcium absorption, reducing diabetes-related illnesses and improving gut health. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
6-Aminocaproic acid-d6 | 99.93% | 6-Aminocaproic acid-d6 is deuterium labeled 6-Aminocaproic acid. 6-Aminocaproic acid (EACA), a monoamino carboxylic acid, is a potent and orally active inhibitor of plasmin and plasminogen. 6-Aminocaproic acid is a potent antifibrinolytic agent. 6-Aminocaproic acid prevents clot lysis through the competitive binding of lysine residues on plasminogen, inhibiting plasmin formation and reducing fibrinolysis. 6-Aminocaproic acid can be used for the research of bleeding disorders. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
6-Aminocaproic acid-d10 | 6-Aminocaproic acid-d10 is the deuterium labeled 6-Aminocaproic acid. 6-Aminocaproic acid (EACA), a monoamino carboxylic acid, is a potent and orally active inhibitor of plasmin and plasminogen. 6-Aminocaproic acid is a potent antifibrinolytic agent. 6-Aminocaproic acid prevents clot lysis through the competitive binding of lysine residues on plasminogen, inhibiting plasmin formation and reducing fibrinolysis. 6-Aminocaproic acid can be used for the research of bleeding disorders. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-Leucine-d10 | 98.0% | (±)-Leucine-d10 is the deuterium labeled (±)-Leucine. (±)-Leucine (DL-Leucine), an isomer of Leucine, chemosterilant and dietary additive. (±)-Leucine inhibits growth of Escherichia coli HfrH by 92.08%. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Lysine-d4 dihydrochloride | 99.75% | DL-Lysine-4,4,5,5-d4 (dihydrochloride) is the deuterium labeled DL-Lysine. DL-Lysine is a racemic mixture of the D-Lysine and L-Lysine. Lysine is an α-amino acid that is used in the biosynthesis of proteins. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Alloisoleucine-d10 | L-Alloisoleucine-d10 is the deuterium labeled L-Alloisoleucine. L-Alloisoleucine is a branched chain amino acid and is a stereo-isomer of L-isoleucine. L-Alloisoleucine is a common constituent of human plasma (albeit at low levels). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Citrulline-d4 | 99.99% | L-Citrulline-d4 is the deuterium labeled L-Citrulline. L-Citrulline is an amino acid derived from ornithine in the catabolism of proline or glutamine and glutamate, or from l-arginine via arginine-citrulline pathway. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Lysine-13C6 dihydrochloride | 99.83% | L-Lysine-13C6 (dihydrochloride) is the 13C-labeled L-Lysine dihydrochloride. L-lysine dihydrochloride is an essential amino acid with important roles in connective tissues and carnitine synthesis, energy production, growth in children, and maintenance of immune functions. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Leucine-d10 | 99.0% | L-Leucine-d10 is the deuterium labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
H-HoArg-OH-d4 | H-HoArg-OH-d4 (L-Homoarginine-d4) is the d4-labeled H-HoArg-OH (HY-W008385). H-HoArg-OH (L-Homoarginine) is an orally active endogenous non-protein amino acid. H-HoArg-OH acts as a weak alternative substrate for NOS and interferes with NO production, selectively inhibits tissue-nonspecific alkaline phosphatase (TNAP), and suppresses the uptake of arginine by y+-type transporters (system y+). H-HoArg-OH increases tissue hArg concentrations in vivo, regulates amino acid homeostasis, and improves renal function and pathological features of diabetic nephropathy. H-HoArg-OH can be used in studies related to diabetes and cardiomyopathy. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Lysine-13C6,15N2 dihydrochloride | 99.98% | L-Lysine-13C6,15N2 (dihydrochloride) is a 15N-labeled and 13C-labled L-Lysine dihydrochloride. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Lysine6-13C dihydrochloride | L-Lysine6-13C (dihydrochloride) is a 13C-labeled L-Lysine dihydrochloride. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Lysine-d4 dihydrochloride | 99.91% | L-Lysine-d4 (dihydrochloride) is the deuterium labeled L-Lysine dihydrochloride. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Lysine-d9 dihydrochloride | L-Lysine-d9 (dihydrochloride) is the deuterium labeled L-Lysine dihydrochloride. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Lysine-15N dihydrochloride | 98.00% | L-Lysine-15N dihydrochloride is a 15N-labeled L-Lysine dihydrochloride. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Ornithine-d7 hydrochloride | 99.62% | L-Ornithine-d7 hydrochloride is the d7-labeled L-Ornithine hydrochloride (HY-W017018). L-Ornithine hydrochloride is an orally active CaSR and p38 activator. L-Ornithine hydrochloride inhibits ROS and supports urea cycle function. L-Ornithine hydrochloride can be used to study kidney diseases involving proximal tubular cell damage caused by oxidative stress or crystallopathy, as well as research related to anxiety disorders. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Lysine Monohydrochloride | 97.0% | DL-Lysine Monohydrochloride is a lysine derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Lysine-d4 dihydrochloride | D-Lysine-d4 dihydrochloride is the d4-labeled D-Lysine (HY-Y1091). D-Lysine is the D-enantiomer of L-Lysine (HY-N0469). D-Lysine is metabolically inert and not utilized for protein synthesis by mammalian ribosomes. D-Lysine blocks renal uptake of 111In/90Y-Octreotide (HY-P0036)-based probes without inhibiting uptake by tumor/receptor tissues, and thus acts as a renoprotective agent in diagnostic imaging and peptide receptor radionuclide therapy (PRRT). D-Lysine specifically inhibits the early steps of non-enzymatic glycation by competing with glucose via its free amino group, theoretically, it can serve as a glycation competitor that "does not interfere with protein synthesis" under chronic hyperglycemia in diabetes. D-Lysine can be used in research related to cancer and diabetes. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Lysine2-15N dihydrochloride | DL-Lysine2-15N (dihydrochloride) is the 15N labeled DL-Lysine2 dihydrochloride. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
CML-d4 | 99.76% | CML-d4 is the deuterium labeled Fmoc-L-Lys (Boc)-OH. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
2-Aminobutanoic-4,4,4 acid hydrochloride-d3 | 2-Aminobutanoic-4,4,4 acid hydrochloride-d3 is the deuterium labeled 2-Aminobutanoic-4,4,4 acid hydrochloride. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
6-Aminocaproic acid-d10 hydrochloride | 6-Aminocaproic acid-d10 hydrochloride (EACA-d10 hydrochloride; Epsilon-Amino-n-caproic Acid-d10 hydrochloride; 6-Aminohexanoic acid-d10 hydrochloride) is the deuterium labeled 6-Aminocaproic acid hydrochloride (HY-B0236A). 6-Aminocaproic acid hydrochloride, a monoamino carboxylic acid, is a potent and orally active inhibitor of plasmin and plasminogen. 6-Aminocaproic acid is a potent antifibrinolytic agent. 6-Aminocaproic acid prevents clot lysis through the competitive binding of lysine residues on plasminogen, inhibiting plasmin formation and reducing fibrinolysis. 6-Aminocaproic acid can be used for the research of bleeding disorders. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Leucine-d10 | 99.96% | D-Leucine-d10 is the deuterium labeled D-Leucine. D-Leucine is a more potent anti-seizure agent than L-leucine. D-leucine potently terminates seizures even after the onset of seizure activity. D-leucine, but not L-leucine, reduces long-term potentiation but had no effect on basal synaptic transmission in vitro. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Norvaline-d5 | 99.9% | L-Norvaline-d5 is the deuterium labeled L-Norvaline. L-Norvaline is the inhibitor for arginase, that promotes the production of NO, reduces oxidative stress, improves insulin resistance, and exhibits antioxidant and anti-hyperglycemic effects. L-Norvaline can be used in research of Alzheimer’s disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Lysine monohydrochloride | 99.72% | D-Lysine monohydrochloride is the D-enantiomer of L-Lysine (HY-N0469). D-Lysine monohydrochloride is metabolically inert and not utilized for protein synthesis by mammalian ribosomes. D-Lysine monohydrochloride blocks renal uptake of 111In/90Y-Octreotide (HY-P0036)-based probes without inhibiting uptake by tumor/receptor tissues, and thus acts as a renoprotective agent in diagnostic imaging and peptide receptor radionuclide therapy (PRRT). D-Lysine monohydrochloride specifically inhibits the early steps of non-enzymatic glycation by competing with glucose via its free amino group, theoretically, it can serve as a glycation competitor that "does not interfere with protein synthesis" under chronic hyperglycemia in diabetes. D-Lysine monohydrochloride can be used in research related to cancer and diabetes. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Lysine monohydrochloride (Standard) | ≥98% | D-Lysine monohydrochloride (Standard) is the analytical standard of D-Lysine monohydrochloride (HY-Y1804). This product is intended for research and analytical applications. D-Lysine monohydrochloride is the D-enantiomer of L-Lysine (HY-N0469). D-Lysine monohydrochloride is metabolically inert and not utilized for protein synthesis by mammalian ribosomes. D-Lysine monohydrochloride blocks renal uptake of 111In/90Y-Octreotide (HY-P0036)-based probes without inhibiting uptake by tumor/receptor tissues, and thus acts as a renoprotective agent in diagnostic imaging and peptide receptor radionuclide therapy (PRRT). D-Lysine monohydrochloride specifically inhibits the early steps of non-enzymatic glycation by competing with glucose via its free amino group, theoretically, it can serve as a glycation competitor that "does not interfere with protein synthesis" under chronic hyperglycemia in diabetes. D-Lysine monohydrochloride can be used in research related to cancer and diabetes. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Lysine-d4 monohydrochloride | D-Lysine-d4 monohydrochloride is the d4 D-Lysine monohydrochloride (HY-Y1804). D-Lysine monohydrochloride is the D-enantiomer of L-Lysine (HY-N0469). D-Lysine monohydrochloride is metabolically inert and not utilized for protein synthesis by mammalian ribosomes. D-Lysine monohydrochloride blocks renal uptake of 111In/90Y-Octreotide (HY-P0036)-based probes without inhibiting uptake by tumor/receptor tissues, and thus acts as a renoprotective agent in diagnostic imaging and peptide receptor radionuclide therapy (PRRT). D-Lysine monohydrochloride specifically inhibits the early steps of non-enzymatic glycation by competing with glucose via its free amino group, theoretically, it can serve as a glycation competitor that "does not interfere with protein synthesis" under chronic hyperglycemia in diabetes. D-Lysine monohydrochloride can be used in research related to cancer and diabetes. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
- L-Lysine-d9 hydrochloride
- L-Lysine hydrochloride (Standard)
- L-Lysine-d3 hydrochloride
- L-Lysine-13C6,15N2 hydrochloride
- L-Lysine-d8 hydrochloride
- L-Lysine-13C dihydrochloride
- L-Lysine-13C6 hydrochloride
- L-Lysine-15N2 hydrochloride
- L-Lysine-d4 hydrochloride
- L-Lysine-13C6,15N2,d9 dihydrochloride
- L-Lysine hydrochloride
